Table 3.
Risk of bias in included studies assessed by the ROBINS-I tool
Risk-of-bias domains | ||||||||
Study, year | Confounding | Selection of participants | Classification of interventions | Deviations from intended intervention | Missing data | Measurement of outcomes | Overall risk of bias | Selection of reported result |
Vaccination before SARS-CoV-2 infection | ||||||||
Al-Aly 202219 | Low | Low | Low | Low | Low | Moderate | Low | Moderate |
Antonelli 202220 | Moderate | Low | Low | Low | Serious | Serious | Low | Serious |
Ayoubkhani 202221 | Critical | Low | Low | Low | Moderate | Low | Low | Critical |
Azzolini 202222 | Moderate | Low | Moderate | Low | NI | Critical | Low | Critical |
Ioannou 202223 | Moderate | Low | Low | Low | NI | Low | Moderate | Moderate |
Mohr 202224 | Serious | Serious | Low | Low | Serious | Moderate | Moderate | Serious |
Pell 202225 | Serious | Low | Serious | Low | Serious | Moderate | Moderate | Serious |
Tannous 202226 | Serious | Low | Low | Low | Low | Serious | NI | Serious |
Taquet 202127 | Moderate | Low | Low | Low | NI | Low | Low | Moderate |
van der Maaden 202228 | Serious | Low | Moderate | Low | Low | Low | Low | Serious |
Zisis 202229 | Serious | Critical | Serious | Low | NI | Serious | NI | Critical |
Vaccination after SARS-CoV-2 infection or after diagnosis of long covid | ||||||||
Ayoubkhani 202230 | Low | Low | Low | Low | Moderate | Low | Low | Moderate |
Simon 202131 | Serious | Low | Low | Low | Moderate | Low | Low | Serious |
Tran 202132 | Moderate | Low | Low | Low | Low | Low | Low | Moderate |
Wisnivesky 202233 | Serious | Serious | Serious | Low | Low | Low | Low | Serious |
Wynberg 202234 | Serious | Moderate | Serious | Low | Low | Serious | Low | Serious |
NI=no information.